Jag Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,232
Closed -$3.16M 166
2023
Q3
$3.16M Buy
7,232
+200
+3% +$99.7K 0.38% 48
2023
Q2
$3.53M Buy
7,032
+233
+3% +$112K 0.41% 47
2023
Q1
$3.4M Buy
6,799
+4,743
+231% +$2.27M 0.44% 51
2022
Q4
$839K Sell
2,056
-560
-21% -$217K 0.12% 104
2022
Q3
$852K Sell
2,616
-18,954
-88% -$6.96M 0.12% 111
2022
Q2
$7.57M Buy
21,570
+2,205
+11% +$899K 0.93% 35
2022
Q1
$9.47M Sell
19,365
-1,699
-8% -$894K 0.94% 35
2021
Q4
$13.9M Sell
21,064
-1,223
-5% -$768K 1.06% 32
2021
Q3
$13.9M Buy
22,287
+1,511
+7% +$1.02M 1.08% 31
2021
Q2
$13.1M Buy
20,776
+1
+0% +$552 1.03% 32
2021
Q1
$10.2M Buy
20,775
+1,252
+6% +$627K 0.9% 35
2020
Q4
$9.76M Buy
19,523
+1,176
+6% +$526K 0.88% 33
2020
Q3
$7.21M Buy
18,347
+1,795
+11% +$664K 0.75% 33
2020
Q2
$5.46M Sell
16,552
-25
-0.2% -$7.24K 0.64% 35
2020
Q1
$4.02M Sell
16,577
-46,660
-74% -$12.2M 0.59% 39
2019
Q4
$16.5M Buy
63,237
+677
+1% +$178K 1.87% 21
2019
Q3
$17M Buy
62,560
+47,121
+305% +$13.1M 2.05% 17
2019
Q2
$4.25M Buy
+15,439
New +$3.8M 0.48% 38

Other funds holding IDXX

Jag Capital Management's IDXX Position: Q4 2023 in Review

Jag Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 7,232 shares — an estimated $3.16M sold.

Jag Capital Management first reported a position in IDXX in Q2 2019 and held it in 18 quarters. The position peaked at $17M in Q3 2019. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • Jag Capital Management reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
  • Jag Capital Management sold 7,232 Idexx Laboratories shares in Q4 2023, an estimated $3.16M.
  • Jag Capital Management first reported a position in Idexx Laboratories in Q2 2019 and held it in 18 quarters.
  • Jag Capital Management's Idexx Laboratories position peaked at $17M in Q3 2019.
  • 1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Jag Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.